Phase I Study to Evaluate the Safety and Pharmacokinetics of Oral Doses of Anvylic-3288 in Healthy Subjects

NCT01851603 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped PI left institution

Conditions

Schizophrenia

Interventions

DEVICE: AVL-3288
DRUG: Placebo

Sponsor

University of Colorado, Denver

Collaborators

[object Object]